LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.”
AstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine’s safety, when dozens of countries suspended the vaccine’s use after unusual but rare blood clots were detected in a small number of immunized people. The EU regulator concluded AstraZeneca’s shot didn’t raise the overall risk of clots, but doubts remained.
Partial results from its first major trial — which Britain used to authorize the vaccine — were clouded by a manufacturing mistake that researchers didn’t immediately acknowledge. Insufficient data about how well the vaccine protected older people led some countries to initially restrict its use to younger populations before reversing course.
Travis Kelce cast in FX's 'American Horror Story: Grotesquerie'
2 civilians injured by Israeli aerial attack in Syrian capital
Tourists Visit Dazu Rock Carvings in Chongqing
Chinese Publishers Examine AI Potential at London Book Fair
Travis Kelce called out for being 'corny' over reaction to romance with Taylor Swift by Jana Kramer
Overseas investors, entities bullish about China's economic growth after industrial data
Mechanism Promotes Public Interest Litigation to Protect Women, Children's Rights, Interests
REVEALED: The full list of celebrities who have admitted to taking Ozempic
People Pay Tribute to Deceased Ahead of Qingming Festival in Beijing
UK Prime Minister Sunak suffers further blow as another Conservative lawmaker defects to Labour
Small town thrives with winter games